Page last updated: 2024-12-05

2,4-dichloro-1-nitrobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID11899
CHEMBL ID166050
SCHEMBL ID487215
MeSH IDM0152133

Synonyms (48)

Synonym
benzene,4-dichloro-1-nitro-
1,3-dichloro-4-nitrobenzene
2,4-dichloro-1-nitrobenzene
611-06-3
2,4-dichloronitrobenzene
nsc-43196
nsc43196
inchi=1/c6h3cl2no2/c7-4-1-2-6(9(10)11)5(8)3-4/h1-3
benzene, 2,4-dichloro-1-nitro-
NCGC00091267-01
brn 1451655
einecs 210-248-3
nsc 43196
hsdb 4267
ccris 3095
GHL.PD_MITSCHER_LEG0.937
2,4-dichloro-1-nitrobenzene, 97%
AC-2533
D0982
CHEMBL166050
A833046
NCGC00091267-02
tox21_200204
cas-611-06-3
dtxcid104998
NCGC00257758-01
dtxsid3024998 ,
nitro-m-dichlorobenzene
unii-85p1a896rr
85p1a896rr ,
ec 210-248-3
FT-0610061
AKOS009156373
2,4-dichloronitrobenzene [hsdb]
dichloronitrobenzene, 2,4-
2, 4-dichloronitrobenzene
2,4-dichloro-nitrobenzene
2,4-dichloronitrobenzen
2,4-dichloro nitro benzene
SCHEMBL487215
W-105195
benzene, 1,3-dichloro-4-nitro
mfcd00007071
GS-3043
2,4-dichloro-1-nitrobenzene, purum, >=98.0% (gc)
benzene, 2,4-dichloro-1-nitro-; 2,4-dichloro-1-nitrobenzene; 1,3-dichloro-4-nitrobenzene; 2,4-dichloronitrobenzene; 4-nitro-1,3-dichlorobenzene; nsc 43196
Q2705544
EN300-49162

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves were generated using Salmonella typhimurium tester strains TA-98 and TA-100 at concentrations of 0, 1, 5, 10, 25, 50, and 100 micrograms per plate in a modified Ames assay."( Dinitrochlorobenzene is inherently mutagenic in the presence of trace mutagenic contaminants.
Connor, TH; Wilkerson, MG; Wilkin, JK, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency7.60210.006038.004119,952.5996AID1159521
AR proteinHomo sapiens (human)Potency41.74580.000221.22318,912.5098AID1259243; AID1259381; AID588516
thyroid stimulating hormone receptorHomo sapiens (human)Potency10.00000.001318.074339.8107AID926; AID938
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency61.56650.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency24.03980.000417.946075.1148AID1346784
retinoid X nuclear receptor alphaHomo sapiens (human)Potency54.26950.000817.505159.3239AID1159527
mitogen-activated protein kinase 1Homo sapiens (human)Potency25.11890.039816.784239.8107AID995
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency35.28560.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID200691Mutagenic activity in Salmonella Typhimurium TA98 using Ames test; Activity is log of revertants / nmol; a= inactive1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.76)18.7374
1990's3 (17.65)18.2507
2000's6 (35.29)29.6817
2010's5 (29.41)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.13 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index36.43 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.88%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]